The Pro-Stim graft provides surgeons with the osteoconductive base material derived from its Pro-Dense graft, which is a combination of calcium sulfate and calcium phosphate materials, but adds a high volume of osteoinductive demineralized bone matrix to the formulation.
A full roll-out in the United States and some international markets is planned for the second half of 2010.
Read Wright Medical Group’s release on the Pro-Stim bone graft substitute.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
